Antithrombin III: physiology, deficiency, and replacement therapy
- 8 July 1992
- journal article
- review article
- Published by Wiley in Transfusion
- Vol. 32 (6), 580-588
- https://doi.org/10.1046/j.1537-2995.1992.32692367206.x
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic diseaseBritish Journal of Haematology, 1991
- Mortality in hereditary antithrombin-III deficiency—1830 to 1989The Lancet, 1991
- ANTITHROMBIN III ACTIVITY IN HEALTHY BLOOD DONORS: AGE AND SEX RELATED CHANGES AND THE PREVALENCE OF ASYMPTOMATIC DEFICIENCYBritish Journal of Haematology, 1990
- Inactivation of HIV in antithrombin-III concentrate by pasteurizationTransfusion, 1988
- Clinical Evaluation of Antithrombin III Concentrate (BI 6.013) for Disseminated Intravascular Coagulation in ObstetricsGynecologic and Obstetric Investigation, 1987
- Clinical and genetic aspects of antithrombin III deficiencyAmerican Journal of Medical Genetics, 1983
- Pregnancy in Women with Congenital Antithrombin III Deficiency: Experience of Treatment with Heparin and AntithrombinGynecologic and Obstetric Investigation, 1982
- Antithrombin III concentrate: its catabolism in health and in antithrombin III deficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1981
- Infusion of Purified Antithrombin III to Patients with Fracture of the Neck of the FemurEuropean Surgical Research, 1979
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977